NIPH Clinical Trials Search

Basic Information

Recruitment status	completed
Health condition(s) or Problem(s) studied
Date of first enrollment	19/06/2020
Target sample size	1800
Countries of recruitment	Japan,North America,Europe,Oceania
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : donanemab Therapeutic category code : 119 Other agents affecting central nervous system Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	efficacy
Secondary Outcome	safety efficacy pharmacokinetics

Key inclusion & exclusion criteria

Age minimum	>= 60age old
Age maximum	<= 85age old
Gender	Both
Include criteria
Exclude criteria